Astellas Pharma Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
1/10
|
171.67 | 37.61 | 356.44% | 46.88 | +266.23% |
| P/S |
|
1.82 | 3.66 | -50.15% |
|
|
| P/BV |
|
1.83 | 3.49 | -47.41% |
|
|
| P/FCF |
|
0.3057 | 13.91 | -97.8% |
|
|
| Ev/Ebitda |
|
18.02 | 12.62 | 42.78% |
|
|
| Ev/S |
|
2.19 | 3.12 | -29.78% |
|
|
| Ev/FCF |
|
39.02 | 15.73 | 148.11% |
|
|
| E/P |
|
0.6196 | 1.62 | -61.78% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
4/10
|
12.15 | 24.95 | -51.32% | 17.02 | -28.61% |
| ROE |
|
1.1 | 12.14 | -90.95% |
|
|
| ROA |
|
0.5657 | 6.04 | -90.64% |
|
|
| ROIC |
|
13.08 | 15.56 | -15.93% |
|
|
| ROS |
|
1.06 | 12.44 | -91.48% |
|
|
| ROCE |
|
2.32 | 11.85 | -80.42% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
1/10
|
4.72 | 6.23 | -24.25% | 2.48 | +90.44% |
| Nеt Debt/Ebitda |
|
3 | -3.84 | -178.04% |
|
|
| Debt/Ratio |
|
0.2577 | 0.222 | 16.08% |
|
|
| Debt/Equity |
|
1.24 | 0.7587 | 63% |
|
|
| Debt/Net Income |
|
53.98 | 16.97 | 218.09% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.76 | -100% | 2.5 | -100% |
| Number of years of dividend growth |
|
0 | 1.49 | -100% | ||
| DSI |
|
0.7857 | 0.7808 | 0.6314% |
|
|
| Average dividend growth |
|
4.99 | -283.9 | -101.76% |
|
|
| Average percentage for 5 years |
|
2.5 | 2.74 | -8.69% |
|
|
| Average percentage for payments |
|
78.54 | 168.74 | -53.45% |
|
|
| Difference from average difference in sector |
|
-1.76 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
4/10
|
23.28 | 36.35 | -35.96% | ||
| Growth impulse Ebitda in 5 years |
|
-43.67 | 28.15 | -255.13% | ||
| Growth impulse Net Income in 5 years |
|
-91.28 | 33.82 | -369.9% | ||
| Growth impulse FCF in 5 years |
|
-37.56 | 13.65 | -375.16% | ||
| Growth impulse EPS in 5 years |
|
-90.91 | 74.17 | -222.57% |
IP Score
3.86/10
